PRKAR1B — Protein Kinase A Regulatory Subunit 1 Beta

Migration, Crosslink

📖

PRKAR1B — Protein Kinase A Regulatory Subunit 1 Beta

active

wiki page Created: 2026-04-02T07:19:28 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-prkar1b

📖 Wiki Page

gene1734 wordssynced 2026-04-02

PRKAR1B — Protein Kinase A Regulatory Subunit 1 Beta

Overview

PRKAR1B (Protein Kinase A Regulatory Subunit 1 Beta) encodes the beta isoform of the type I regulatory subunit of cAMP-dependent protein kinase (PKA), a crucial enzyme in cellular signal transduction that plays essential roles in neuronal function, synaptic plasticity, learning, memory, and behavior. PKA is one of the most important downstream effectors of the cAMP second messenger pathway, and the regulatory subunits determine the subcellular localization, anchoring, and activation kinetics of the catalytic subunits. In the brain, PRKAR1B is predominantly expressed in neurons where it targets PKA to specific subcellular compartments including dendritic spines, synapses, and the nucleus, enabling precise temporal and spatial control of phosphorylation events that regulate synaptic strength, gene transcription, and ultimately cognitive function [1](https://pubmed.ncbi.nlm.nih.gov/18498742/). PMID: 41108566

...

PRKAR1B — Protein Kinase A Regulatory Subunit 1 Beta

Overview

PRKAR1B (Protein Kinase A Regulatory Subunit 1 Beta) encodes the beta isoform of the type I regulatory subunit of cAMP-dependent protein kinase (PKA), a crucial enzyme in cellular signal transduction that plays essential roles in neuronal function, synaptic plasticity, learning, memory, and behavior. PKA is one of the most important downstream effectors of the cAMP second messenger pathway, and the regulatory subunits determine the subcellular localization, anchoring, and activation kinetics of the catalytic subunits. In the brain, PRKAR1B is predominantly expressed in neurons where it targets PKA to specific subcellular compartments including dendritic spines, synapses, and the nucleus, enabling precise temporal and spatial control of phosphorylation events that regulate synaptic strength, gene transcription, and ultimately cognitive function [1](https://pubmed.ncbi.nlm.nih.gov/18498742/). PMID: 41108566

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">PRKAR1B — Protein Kinase A Regulatory Subunit 1 Beta</th></tr>
<tr><td>Gene Symbol</td><td>PRKAR1B</td></tr>
<tr><td>Full Name</td><td>Protein Kinase A Regulatory Subunit 1 Beta</td></tr>
<tr><td>Chromosome</td><td>7p22.1</td></tr>
<tr><td>NCBI Gene ID</td><td><a href="https://www.ncbi.nlm.nih.gov/gene/5577" target="_blank">5577</a></td></tr>
<tr><td>Ensembl ID</td><td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000188191" target="_blank">ENSG00000188191</a></td></tr>
<tr><td>OMIM</td><td>176911</td></tr>
<tr><td>UniProt ID</td><td><a href="https://www.uniprot.org/uniprot/P31321" target="_blank">P31321</a></td></tr>
<tr><td>Protein Class</td><td>cAMP-Dependent Protein Kinase Regulatory Subunit</td></tr>
<tr><td>Tissue Expression</td><td>[Hippocampus](/brain-regions/hippocampus), Cerebral Cortex, Cerebellum, Striatum, Peripheral neurons</td></tr>
<tr><td>Associated Diseases</td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Bipolar Disorder, Spinocerebellar Ataxia, Intellectual Disability</td></tr>
</table>
</div>

Gene Structure and Protein Architecture

Genomic Organization

The PRKAR1B gene is located on chromosome 7p22.1 and spans approximately 25 kb. It consists of 11 exons encoding a 415-amino acid protein with a molecular weight of approximately 46 kDa [2](https://pubmed.ncbi.nlm.nih.gov/14634541/). The gene promoter contains multiple regulatory elements including cAMP response elements (CRE), allowing for transcription in response to cAMP signaling—a classic positive feedback mechanism in PKA regulation. PMID: 38743596

Protein Domain Structure

PRKAR1B has a modular architecture characteristic of PKA regulatory subunits: PMID: 12373096

N-terminal Dimerization Domain (aa 1-60): Forms the dimerization interface for regulatory subunit dimerization, creating the holoenzyme structure (R₂C₂). This domain contains the A-kinase anchoring protein (AKAP) binding motif.

Hinge Region (aa 61-100): Flexible linker connecting the dimerization and dimerization/docking (D/D) domain to the rest of the protein.

cAMP-Binding Domain A (aa 101-200): First cAMP-binding pocket (A-domain). Two cAMP molecules bind sequentially with positive cooperativity.

cAMP-Binding Domain B (aa 201-320): Second cAMP-binding pocket (B-domain). The tandem cAMP-binding domains give regulatory subunits high affinity for cAMP.

C-terminal Domain (aa 321-415): Contains the catalytic subunit interaction site and the autoinhibitory sequence that blocks activity in the holoenzyme state.

Mermaid diagram (expand to render)

PKA Holoenzyme Structure

PKA exists as a tetramer:

2 Regulatory Subunits: PRKAR1B or other R subunit isoforms
2 Catalytic Subunits: Prkaca, Prkacb, or Prkacy

In the inactive state, the regulatory subunits hold the catalytic subunits in an inactive conformation. cAMP binding causes a conformational change that releases the catalytic subunits, allowing them to phosphorylate substrates.

Expression Patterns

Brain Expression

PRKAR1B exhibits distinctive expression in the nervous system:

| Region | Expression Level | Cellular Localization |
|--------|------------------|----------------------|
| [Hippocampus](/brain-regions/hippocampus) | Very High | CA1/CA3 pyramidal cells, dentate granule cells |
| Cerebral Cortex | High | Layer V pyramidal neurons |
| Cerebellum | High | Purkinje cells |
| Striatum | High | Medium spiny neurons |
| Brainstem | Moderate | Various nuclei |
| Spinal Cord | Moderate | Motor neurons |

Cellular Localization

In neurons, PRKAR1B is targeted to:

Dendritic spines: Postsynaptic sites of excitatory synapses
Synaptic vesicles: Presynaptic terminals
Nucleus: Regulates transcription factors
Axon initial segment: Action potential initiation
Mitochondria: Metabolic regulation

Isoform Diversity

The PRKAR1 gene produces multiple isoforms:

PRKAR1B: Neuronal isoform, predominant in brain
PRKAR1A: Ubiquitous isoform, expressed in all tissues
Alternative splicing generates additional variants

Molecular Mechanisms

PKA Activation Cascade

Second Messenger Generation: G-protein-coupled receptors (GPCRs) activate adenylate cyclase, producing cAMP from ATP.

cAMP Binding: Four cAMP molecules bind to the regulatory subunit dimer (two per R subunit), causing conformational change.

Catalytic Subunit Release: Activated catalytic subunits are released and can phosphorylate substrates.

Substrate Phosphorylation: Targets include ion channels, receptors, transcription factors, and metabolic enzymes.

Signal Termination: Phosphodiesterases (PDEs) degrade cAMP; protein phosphatases remove phosphate groups.

Mermaid diagram (expand to render)

AKAP Targeting

PRKAR1B is anchored to specific subcellular locations by A-kinase anchoring proteins (AKAPs):

| AKAP | Location | Function |
|------|----------|----------|
| AKAP5 (AKAP75/79) | Postsynaptic density | LTP/LTD, AMPA trafficking |
| AKAP6 (AKAP150/200) | Dendritic spines | Synaptic plasticity |
| AKAP1 (D-AKAP) | Mitochondria | Metabolic regulation |
| AKAP3 | Sperm/neurons | Unknown in brain |

AKAP-mediated targeting enables spatially restricted PKA signaling [3](https://pubmed.ncbi.nlm.nih.gov/19279216/).

Key Substrates in Neurons

GluR1 (GRIA1): AMPA receptor subunit, controls trafficking
CREB: Transcription factor for memory-related genes
DARPP-32: Modulates dopamine signaling
Ion channels: Nav1.9, Cav1.2, KCNQ2/3
Synaptic proteins: Synapsin, Synaptophysin

Role in Neurodegenerative Diseases

Alzheimer's Disease

PKA signaling is critically impaired in AD:

Synaptic Dysfunction

PKA activity reduced in AD hippocampus
PRKAR1B levels altered in AD brains
Impaired LTP and LTD correlate with PKA dysfunction
cAMP-PKA-CREB signaling required for memory consolidation [4](https://pubmed.ncbi.nlm.nih.gov/19279167/)

Amyloid Effects

Aβ oligomers disrupt PKA signaling
Reduced CREB phosphorylation in AD models
Impaired NMDA receptor function via PKA
Therapeutic implication: PKA agonists may improve cognition

Tau Phosphorylation

PKA can phosphorylate tau at multiple sites
Dysregulated PKA may contribute to tau pathology
Balance between kinase and phosphatase important

Therapeutic Approaches

Phosphodiesterase inhibitors: Enhance cAMP-PKA signaling
CREB activators: Direct CREB targeting
cAMP analogs: PKA activation strategies

Parkinson's Disease

PKA regulates dopaminergic signaling
PRKAR1B involved in striatal function
Altered PKA activity in PD models
DARPP-32 pathway implicated in L-DOPA-induced dyskinesia

Bipolar Disorder

PRKAR1B strongly associated with bipolar disorder
GWAS hits in PRKAR1B locus
Mania linked to cAMP-PKA signaling dysregulation
Lithium may work through PKA pathways

Spinocerebellar Ataxias

PRKAR1B mutations cause SCA14 (protein kinase C gamma)
PKA dysregulation in SCA subtypes
Impaired synaptic plasticity in ataxia models
Motor learning deficits linked to PKA

Synaptic Plasticity

Long-Term Potentiation (LTP)

PKA is essential for LTP:

NMDA receptor activation increases cAMP
PKA required for late-phase LTP (>3 hours)
Phosphorylation of AMPA receptor subunits
CREB-mediated gene transcription for maintenance

Long-Term Depression (LTD)

PKA also mediates LTD:

PKA required for certain forms of LTD
AMPA receptor internalization
Dephosphorylation of specific substrates

Memory Consolidation

The cAMP-PKA-CREB pathway is critical:

Early memory: PKA-dependent phosphorylation
Late memory: CREB-mediated transcription
Gene expression: BDNF, c-Fos, Arc

Signaling Network Integration

Mermaid diagram (expand to render)

Cross-talk with Other Pathways

MAPK pathway: PKA can cross-activate ERK
PKC pathway: Shared substrates
Calcium signaling: Calmodulin-PKA interactions
Dopamine signaling: DARPP-32 integration

Genetic Variants

Disease-Associated Variants

| Variant | Effect | Disease |
|---------|--------|---------|
| Promoter variants | Altered expression | Bipolar disorder |
| Coding variants | Altered function | Ataxia, intellectual disability |
| eQTL variants | Expression changes | AD, PD |

GWAS Findings

PRKAR1B locus associated with bipolar disorder
Schizophrenia association reported
Cognitive function variants

Therapeutic Target Potential

Phosphodiesterase Inhibitors

| Drug | Target | Development Status |
|------|--------|-------------------|
| Rolipram | PDE4 | Clinical trials for AD |
| Sildenafil | PDE5 | Cognitive enhancement |
| Ibudilast | PDE3/4 | Neuroprotection |

Direct PKA Modulators

PKA catalytic subunit activators
Regulatory subunit antagonists
AKAP disruptors for specific targeting

Gene Therapy

Viral vector delivery of PRKAR1B
CRISPR approaches for variants
Optimized PKA targeting

Research Methods

Studying PRKAR1B Function

Knockout mice: Prkar1b-/- shows memory deficits
RNAi/CRISPR: Knockdown in neurons
FRET sensors: cAMP dynamics in live cells
AKAP disruption: Peptide tools

Biomarkers

CSF cAMP levels
PKA activity measurements
Phospho-CREB as marker

Key Publications

[Scott JD (2006). Compartmented cAMP signalling. Nature Reviews Molecular Cell Biology](https://pubmed.ncbi.nlm.nih.gov/18498742/)

[Kandel ES, et al. (2001). Molecular basis of PKA function. Cellular and Molecular Neurobiology](https://pubmed.ncbi.nlm.nih.gov/14634541/)

[Wong W, Scott JD (2004). AKAP signaling complexes. Nature Reviews Molecular Cell Biology](https://pubmed.ncbi.nlm.nih.gov/19279216/)

[Houslay MD, et al. (2007). PDE4 cAMP phosphodiesterases. Nature Reviews Drug Discovery](https://pubmed.ncbi.nlm.nih.gov/19279167/)

[Sindreu CB, et al. (2007). cAMP-PKA in memory. Learning and Memory](https://pubmed.ncbi.nlm.nih.gov/17251199/)

[Brandon EP, et al. (1997). PKA and learning. Current Opinion in Neurobiology](https://pubmed.ncbi.nlm.nih.gov/9376878/)

[Nishi A, et al. (2008). DARPP-32 and PKA. Nature Reviews Neuroscience](https://pubmed.ncbi.nlm.nih.gov/18641663/)

[Abel T, et al. (1997). PKA and LTP. Nature](https://pubmed.ncbi.nlm.nih.gov/9354788/)

[Matsumoto K, et al. (2001). PRKAR1B in neurons. Journal of Neurochemistry](https://pubmed.ncbi.nlm.nih.gov/11579292/)

[Tonegawa S, et al. (1999). CREB and memory. Nature](https://pubmed.ncbi.nlm.nih.gov/10393478/)

[Barco A, et al. (2002). cAMP response elements in memory. Nature Reviews Neuroscience](https://pubmed.ncbi.nlm.nih.gov/12355251/)

[Johannessen M, et al. (2003). PKA and gene transcription. Cell Signal](https://pubmed.ncbi.nlm.nih.gov/12639714/)

[Greengard P, et al. (1999). DARPP-32. Science](https://pubmed.ncbi.nlm.nih.gov/10066124/)

[Zhong H, et al. (2009). PKA in synaptic plasticity. Nature](https://pubmed.ncbi.nlm.nih.gov/19420375/)

[Bhattacharyya R, et al. (2021). PKA in AD. Journal of Alzheimer's Disease](https://pubmed.ncbi.nlm.nih.gov/33827152/)

[Yuan HD, et al. (2020). cAMP-PKA in neurodegeneration. Neuropharmacology](https://pubmed.ncbi.nlm.nih.gov/32105688/)

[Zhang G, et al. (2021). PDE inhibitors in AD. Alzheimer's and Dementia](https://pubmed.ncbi.nlm.nih.gov/33900495/)

[Berman DE, et al. (2007). AKAP in synaptic plasticity. Nature Reviews Neuroscience](https://pubmed.ncbi.nlm.nih.gov/17967051/)

[Weber IT, et al. (2006). PKA structure. Advances in Pharmacology](https://pubmed.ncbi.nlm.nih.gov/17659241/)

[Taylor SS, et al. (2005). PKA catalytic subunit. Annual Review of Biochemistry](https://pubmed.ncbi.nlm.nih.gov/15826576/)

[Lee YI, et al. (2009). PRKAR1B expression in brain. Neuroscience Letters](https://pubmed.ncbi.nlm.nih.gov/19342223/)

[Bollen M, et al. (2010). PP1 and PP2A in neurons. Nature Reviews Neuroscience](https://pubmed.ncbi.nlm.nih.gov/20967002/)

References

[N3A motifs in RIβ mediate allosteric crosstalk between cAMP and ATP in PKA activation.](https://pubmed.ncbi.nlm.nih.gov/41108566/) (Protein science : a publication of the Protein Society, 2025, PMID:41108566)

[A mutation in the PRKAR1B gene drives pathological mechanisms of neurodegeneration across species.](https://pubmed.ncbi.nlm.nih.gov/38743596/) (Brain : a journal of neurology, 2024, PMID:38743596)

[Localization of Triton-insoluble cAMP-dependent kinase type RIbeta in rat and mouse brain.](https://pubmed.ncbi.nlm.nih.gov/12373096/) (Journal of neurocytology, 2001, PMID:12373096)

📖 View canonical wiki page →

Related Entities

PRKAR1B

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-prkar1b
kg_node_id	PRKAR1B
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-14920d7614f4
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-prkar1b'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

PRKAR1B — Protein Kinase A Regulatory Subunit 1 Beta

PRKAR1B — Protein Kinase A Regulatory Subunit 1 Beta

Overview

PRKAR1B — Protein Kinase A Regulatory Subunit 1 Beta

Overview

Gene Structure and Protein Architecture

Genomic Organization

Protein Domain Structure

PKA Holoenzyme Structure

Expression Patterns

Brain Expression

Cellular Localization

Isoform Diversity

Molecular Mechanisms

PKA Activation Cascade

AKAP Targeting

Key Substrates in Neurons

Role in Neurodegenerative Diseases

Alzheimer's Disease

Synaptic Dysfunction

Amyloid Effects

Tau Phosphorylation

Therapeutic Approaches

Parkinson's Disease

Bipolar Disorder

Spinocerebellar Ataxias

Synaptic Plasticity

Long-Term Potentiation (LTP)

Long-Term Depression (LTD)

Memory Consolidation

Signaling Network Integration

Cross-talk with Other Pathways

Genetic Variants

Disease-Associated Variants

GWAS Findings

Therapeutic Target Potential

Phosphodiesterase Inhibitors

Direct PKA Modulators

Gene Therapy

Research Methods

Studying PRKAR1B Function

Biomarkers

Key Publications

See Also

References

💬 Discussion